Biogen Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$733.51 | $636.99 | 14.18% | 9 | $654.24B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr886.60 | kr696.07 | 8.28% | 14 | kr3.86T |
| JNJ | Johnson & Johnson | Outperform |
9
|
$146.14 | $174.55 | 16.33% | 3 | $356.43B |
| MRK | Merck | Outperform |
2
|
$131.20 | $130.51 | 8.61% | 11 | $321.69B |
| ABBV | AbbVie | Outperform |
9
|
$159.62 | $178.42 | 16.53% | 11 | $296.21B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£119.88 | £165.99 | 35.93% | 16 | £186.43B |
| NOVN | Novartis | Hold |
10
|
CHF89.50 | CHF105.00 | 20.25% | 9 | CHF181.47B |
| ROG | Roche Holding | Hold |
16
|
CHF221.00 | CHF307.83 | 23.30% | 9 | CHF178.76B |
| DHR | Danaher | Outperform |
10
|
$246.58 | $260.33 | 9.50% | 4 | $182.06B |
| PFE | Pfizer | Outperform |
2
|
$25.40 | $32.87 | 20.08% | 6 | $147.23B |
| AMGN | Amgen | Outperform |
4
|
$269.98 | $303.65 | 17.51% | 8 | $144.81B |
| SAN | Sanofi | Outperform |
16
|
91.23€ | 102.80€ | 19.48% | 9 | 109.51€B |
| MDT | Medtronic | Outperform |
11
|
$79.74 | $92.47 | 19.76% | 21 | $105.54B |
| VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$397.48 | $457.59 | 13.21% | 11 | $101.91B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$883.20 | $961.26 | 18.89% | 8 | $96.37B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.85 | $58.15 | 21.52% | 10 | $90.60B |
| CSL | CSL | Outperform |
12
|
$273.30 | $205.51 | -25.66% | 5 | $130.23B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.42 | $87.82 | 22.29% | 14 | $81.39B |
| GSK | GSK | Outperform |
12
|
£16.53 | £17.30 | 17.97% | 12 | £67.54B |
| MRK | Merck KGaA | Outperform |
18
|
151.75€ | 190.06€ | 20.59% | 4 | 63.48€B |
| ZTS | Zoetis | Outperform |
18
|
$158.42 | $220.47 | 39.50% | 5 | $66.94B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | ¥4.74k | 11.27% | 0 | ¥6.38T |
| MRNA | Moderna | Outperform |
16
|
$107.97 | $135.42 | 15.22% | 1 | $38.83B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
105.30€ | 114.60€ | 13.96% | 0 | 27.62€B |
| BAYN | Bayer | Hold |
5
|
27.40€ | 45.15€ | 9.49% | 4 | 25.86€B |
| DIM | Sartorius Stedim Biotech | Outperform |
18
|
208.30€ | 254.69€ | 15.94% | 3 | 19.52€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.95k | kr2.71k | 31.24% | 14 | kr130.39B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$143.31 | $245.24 | 50.02% | 7 | $18.26B |
| CE | Celanese | Hold |
13
|
$154.49 | $148.23 | 3.57% | 18 | $17.23B |
| 4503 | Astellas Pharma | Outperform |
18
|
¥1.51k | ¥2.64k | 34.46% | 0 | ¥2.70T |
| SY1 | Symrise | Outperform |
18
|
99.86€ | 106.97€ | 12.66% | 5 | 13.96€B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$80.91 | $111.56 | 35.95% | 5 | $15.35B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.81 | $11.59 | 15.86% | 9 | $14.57B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.25k | Rp5.67k | -3.25% | 25 | Rp989.58B |
| UTHR | United Therapeutics | Outperform |
12
|
$233.85 | $284.08 | 27.00% | 3 | $11.20B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$128.77 | $158.66 | 28.52% | 6 | $10.85B |
| 4523 | Eisai | Outperform |
18
|
¥6.24k | ¥9.58k | 34.62% | 0 | ¥1.69T |
| SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr281.00 | kr293.00 | 15.66% | 6 | kr90.51B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.03 | £65.12 | 8.44% | 6 | £6.49B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$41.59 | $55.60 | 44.75% | 3 | $6.37B |
| WCH | Wacker Chemie | Outperform |
17
|
100.30€ | 145.36€ | 24.63% | 9 | 5.06€B |
| GRF | Grifols | Outperform |
18
|
8.39€ | 18.48€ | 126.46% | 3 | 4.76€B |
| CLN | Clariant | Outperform |
18
|
CHF13.26 | CHF16.11 | 13.12% | 6 | CHF4.33B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$31.94 | $44.75 | 23.98% | 0 | $4.17B |
| ALKS | Alkermes | Outperform |
10
|
$24.68 | $33.27 | 37.76% | 3 | $4.13B |
| BIOCON | Biocon | Hold |
14
|
Rp306.40 | Rp270.86 | -13.51% | 14 | Rp312.41B |
| 4403 | NOF | Buy |
18
|
¥2.09k | ¥7.63k | 35.60% | 0 | ¥495.24B |
| TGTX | TG Therapeutics | Outperform |
9
|
$13.47 | $29.44 | 152.41% | 6 | $2.13B |
| DYN | Dyne Therapeutics | Buy |
5
|
$24.73 | $28.13 | 45.57% | 0 | $2.06B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥4.34k | ¥8.34k | 49.94% | 0 | ¥283.22B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$14.65 | $23.40 | 67.24% | 4 | $1.29B |
| WVE | Wave Life Sciences | Outperform |
6
|
$4.66 | $9.21 | 189.70% | 3 | $768.25M |
| STOK | Stoke Therapeutics | Buy |
4
|
$12.41 | $19.33 | 69.22% | 3 | $624.90M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.73 | $6.34 | 98.90% | 0 | $474.02M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.14 | $10.21 | 103.08% | 7 | $425.13M |
| AMRN | Amarin | Hold |
8
|
$0.87 | $2.05 | 14.94% | 1 | $352.89M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.04 | $10.86 | 292.16% | 3 | $266.16M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.09 | $0.30 | 288.89% | 1 | $294.90M |
| NKTR | Nektar Therapeutics | Hold |
11
|
$1.32 | $2.75 | -24.24% | 2 | $171.69M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.18 | $0.65 | 455.56% | 0 | $56.27M |
| ACST | Acasti Pharma | Buy |
0
|
$2.90 | $16.34 | 177.93% | 0 | $26.98M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.85 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
| NPHC | Nutra Pharma | - |
0
|
$0.00 | $0.53 | 0.00% | 0 | $0.01M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |